Prelabor Rupture of Membranes Clinical Trial
— BILROM-TOLACOfficial title:
Mechanical Induction of Labor in Women With Previous Cesarean Section and Premature Rupture of Membranes Who Desire TOLAC: A Prospective Randomized Study
A prospective randomized controlled trial to evaluate the safety and efficacy of labor induction with a double balloon catheter (Atad Ripener Device) in women desiring TOLAC (trial of labor after cesarean) with PROM (pre labor rupture of membranes).
Status | Recruiting |
Enrollment | 200 |
Est. completion date | March 2021 |
Est. primary completion date | March 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years to 45 Years |
Eligibility |
Inclusion Criteria: Only patients who meet the following criteria will be approached. 1. Singleton Pregnancy 2. Previous single cesarean section 3. At least 12 months have elapsed since the previous caesarean delivery 4. Diagnosed with confirmed PROM at = 34 weeks' gestation. 5. Ruptured membranes have occurred =24 hours prior to inclusion in the study. 6. Vertex presentation well applied to the cervix 7. Found to have an unripe cervix in a speculum examination (Bishop score =6). 8. Absence of significant and regular uterine contraction (<3/10Min). 9. Willingness to comply with the protocol for the duration of the study. 10. Have signed an informed consent (including a TOLAC consent form). Exclusion Criteria: Patients having any of the following conditions will be excluded from the study: 1. Any contraindication for a vaginal delivery (i.e. placenta previa, non-vertex presentation, previous cesarean delivery < 12 months). 2. Regular uterine contractions (>3/10Min). 3. Diagnosis of ruptured membranes was made over 24 hours prior to study inclusion. 4. Meconium stained amniotic fluid. 5. Evidence of chorio-amnionitis (T 37.6°C with uterine tenderness and maternal or fetal tachycardia or purulent discharge or WBC20.000) 6. Suspected placental abruption or a significant hemorrhage. 7. Non-reassuring fetal status (as determined by fetal heart rate monitoring and/or bio-physical profile) necessitating immediate intervention. |
Country | Name | City | State |
---|---|---|---|
Israel | Soroka University Medical Center | Be'er Sheva |
Lead Sponsor | Collaborator |
---|---|
Soroka University Medical Center |
Israel,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Vaginal birth after cesarean (VBAC) rates | 5 days | ||
Secondary | PROM to delivery interval (time) | 5 days | ||
Secondary | intrapartum and post-partum infection rates | 5 days | ||
Secondary | Cesarean section rates | 5 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05333731 -
Oxytocin Induction in Full Term Pregnant Women With Cesarean Section of Prelabor Rupture of Membranes
|
||
Recruiting |
NCT04558996 -
Spanish Registry of Pregnant Women With COVID-19
|
||
Not yet recruiting |
NCT05430711 -
Dinoprostone Induction vs. Expectant Management After PROM at Term
|
Phase 4 | |
Not yet recruiting |
NCT00294242 -
Safety Study of Membrane Sweeping in Pregnancy
|
Phase 3 | |
Completed |
NCT05215873 -
Induction of Labor in Pregnant Women With Prelabor Rupture of Membranes - Oxytocin or Misoprostol
|
Phase 4 | |
Recruiting |
NCT04143685 -
Labor Induction With Misoprostol Versus Oxytocin in Women With Premature Rupture of Membranes
|
N/A |